Cargando…
Hepatic manifestations of coronavirus disease 2019 infection: Clinical and laboratory perspective
The novel coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, has become a global challenge of unprecedented nature since December 2019. Although most patients with COVID-19 exhibit mild clinical manifestations and upper respiratory tract involvem...
Autores principales: | Hanif, Farina M, Majid, Zain, Ahmed, Shoaib, Luck, Nasir H, Mubarak, Muhammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724207/ https://www.ncbi.nlm.nih.gov/pubmed/36483109 http://dx.doi.org/10.5501/wjv.v11.i6.453 |
Ejemplares similares
-
Revolution in the diagnosis and management of hepatitis C virus infection in current era
por: Hanif, Farina M, et al.
Publicado: (2022) -
Impact of coronavirus disease 2019 on prevention and elimination strategies for hepatitis B and hepatitis C
por: Rehman, Syed Tabish, et al.
Publicado: (2021) -
Neurological manifestations of hepatitis E virus infection: An overview
por: Jha, Ashish Kumar, et al.
Publicado: (2021) -
To determine the prognostic value of the albumin–bilirubin grade (ALBI) in patients underwent transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Khalid, Muhammad Ali, et al.
Publicado: (2019) -
Coronavirus disease 2019 and renal transplantation
por: Nassar, Mahmoud, et al.
Publicado: (2021)